Skip to main content
Log in

Reimbursement in Canada: time to rethink the evidence?

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Rocchi A, Menon D, Verma S, Miller E.The role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyond. Value in Health 11: 771-783, No. 4, Jul-Aug 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reimbursement in Canada: time to rethink the evidence?. Pharmacoecon. Outcomes News 562, 2 (2008). https://doi.org/10.2165/00151234-200805620-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805620-00002

Keywords

Navigation